"Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy"
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01694433|
Recruitment Status : Completed
First Posted : September 27, 2012
Results First Posted : May 7, 2019
Last Update Posted : May 7, 2019
|Condition or disease||Intervention/treatment||Phase|
|Acne Vulgaris||Drug: Calcipotriene Drug: Placebo||Phase 2 Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||66 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Double (Participant, Investigator)|
|Official Title:||Innate Immunity in Acne Vulgaris|
|Study Start Date :||February 2013|
|Actual Primary Completion Date :||January 9, 2014|
|Actual Study Completion Date :||January 9, 2014|
Experimental: Calcipotriene Cream
The Calcipotriene Cream will be supplied as 1g daily use individual tubes to be used 2x/day (once in the morning and once in the evening) for 12 weeks.
1g daily BID
Placebo Comparator: Placebo
The Placebo Cream will be supplied as 1g daily use individual tubes to be used 2x/day (once in the morning and once in the evening) for 12 weeks.
1g daily BID
Other Name: Placebo cream manufactured to mimic calcipotriene
- Lesion Counts (Total, Inflammatory and Non-inflammatory) [ Time Frame: Weeks 2, 4, 8 & 12 ]Lesion counts will be assessed by one of the investigator physicians or nurse practitioner.
- Acne Severity as Assessed With the Investigator's Global Assessment (IGA) [ Time Frame: Weeks 2, 4, 8 & 12 ]Investigator's Global Assessment (IGA) is a 5-point scale of acne severity, ranging from 0 (Clear) to 4 (Severe)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01694433
|United States, California|
|Los Angeles, California, United States, 90095|
|Principal Investigator:||Jenny Kim, MD,PhD||UCLA Department of Medicine/Division of Dermatology and Nutrition|